April 29, 2021
According to the research report titled ‘GLOBAL Cardiovascular Ultrasound System Market 2019-2027’, available with Market Study Report LLC, global cardiovascular ultrasound system market is expected to record a compound annual growth rate of 5.31% through 2027.
The explosive growth of this business space can be attributed to the increased pervasiveness of cardiovascular diseases, rising adoption of sedentary lifestyle, and mounting consumption of alcohol and tobacco.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2487444/
Cardiovascular diseases (CVD) is the leading cause of death across the globe. Although WHO predicts that around 25% CVD-related deaths have declined owing to the decreased intake of alcohol and consumption.
Technological advancements in this business sphere, escalating healthcare expenditure, and shifting preferences towards minimally invasive surgeries are also stimulating global cardiovascular ultrasound system industry.
However, high cost of such surgeries, lack of reimbursement policies, and easy availability of alternative technologies could potentially act as a bottleneck to the industry expansion.
Regionally, North America is likely to hold the largest market share in the ensuing years, with United States standing tall in terms of revenue hierarchy. The U.S. is known to be the largest consumer of medical devices and equipment across the globe. Rising number of CVD-related deaths, surging healthcare expenditure, and widespread adoption of cardiac devices are adding traction to North America cardiovascular ultrasound system industry size.
The competitive landscape of global cardiovascular ultrasound system industry is defined by companies such as Unetixs Vascular Inc., Esaote S.p.A., GE Healthcare, Ultrasound Technologies Ltd., Mindray Medical International Limited, CHISON Medical Imaging Co. Ltd., Stryker Corp., Fujifilm Holdings Corporation, Abbott Laboratories, Canon Medical Systems Corporation, Koninklijke Philips N.V., Hitachi Medical Corporation, Boston Scientific Corp., AtriCure Inc., and Samsung Electronics Co. Ltd. among others.